SUPPLEMENT

Q1 2025 — Financial statement information

Q1 2025PDF · 11 pages222 KB
Three months ended
March 31,
2025 2024
Net sales $ 5,954 $ 6,016
Operating expenses
Cost of sales 3,478 3,485
Selling, general and administrative expenses 945 1,128
Research, development and related expenses 285 254
Total operating expenses 4,708 4,867
Operating income 1,246 1,149
Other expense (income), net (139) 220
Income from continuing operations before income taxes 1,385 929
Provision for income taxes 265 220
Income from continuing operations of consolidated group 1,120 709
Income from unconsolidated subsidiaries, net of taxes 2 1
Net income from continuing operations including noncontrolling interest 1,122 710
Less: net income attributable to noncontrolling interest 6 5
Net income from continuing operations attributable to 3M 1,116 705
Net income from discontinued operations, net of taxes — 223
Net income attributable to 3M $ 1,116 $ 928
Earnings per share attributable to 3M common shareholders:
Weighted average 3M common shares outstanding — basic 543.8 555.0
Earnings per share from continuing operations — basic $ 2.05 $ 1.27
Earnings per share from discontinued operations — basic — 0.40
Earnings per share — basic $ 2.05 $ 1.67
Weighted average 3M common shares outstanding — diluted 547.7 555.9
Earnings per share from continuing operations — diluted $ 2.04 $ 1.27
Earnings per share from discontinued operations — diluted — 0.40
Earnings per share — diluted $ 2.04 $ 1.67
3M Company and Subsidiaries
CONSOLIDATED STATEMENT OF INCOME
(Millions, except per-share amounts)
(Unaudited)
1

-- 1 of 11 --

March 31, 2025 December 31, 2024
Assets
Current assets
Cash and cash equivalents $ 6,326 $ 5,600
Marketable securities – current 698 2,128
Accounts receivable – net 3,501 3,194
Inventories 3,869 3,698
Prepaids 485 493
Other current assets 778 771
Total current assets 15,657 15,884
Property, plant and equipment – net 7,356 7,388
Operating lease right of use assets 587 565
Goodwill and intangible assets – net 7,522 7,491
Other assets 8,829 8,540
Total assets $ 39,951 $ 39,868
Liabilities and equity
Current liabilities
Short-term borrowings and current portion of long-term debt $ 1,169 $ 1,919
Accounts payable 2,756 2,660
Accrued payroll 451 712
Accrued income taxes 359 331
Operating lease liabilities – current 176 163
Other current liabilities 4,540 5,471
Total current liabilities 9,451 11,256
Long-term debt 12,307 11,125
Other liabilities 13,670 13,593
Total liabilities 35,428 35,974
Total equity 4,523 3,894
Shares outstanding
March 31, 2025: 538,181,362
December 31, 2024: 539,470,303
Total liabilities and equity $ 39,951 $ 39,868
3M Company and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEET
(Dollars in millions)
(Unaudited)
2

-- 2 of 11 --

Three months ended March 31,
2025 2024
Net cash provided by (used in) operating activities $ (79) $ 767
Cash flows from investing activities:
Purchases of property, plant and equipment (236) (375)
Purchases and proceeds from sale or maturities of marketable
securities and investments – net 1,441 (11)
Other investing activities 15 (7)
Net cash provided by (used in) investing activities 1,220 (393)
Cash flows from financing activities:
Change in debt – net 349 5,509
Purchases of treasury stock (1,274) (21)
Proceeds from issuances of treasury stock pursuant to stock option and
benefit plans 905 18
Dividends paid to shareholders (396) (835)
Other financing activities (6) (50)
Net cash provided by (used in) financing activities (422) 4,621
Effect of exchange rate changes on cash and cash equivalents 7 (17)
Net increase (decrease) in cash and cash equivalents 726 4,978
Cash and cash equivalents at beginning of year 5,600 5,933
Cash and cash equivalents at end of period $ 6,326 $ 10,911
The Consolidated Statements of Cash Flows include the results of continuing and discontinued operations and, therefore, also include cash
and cash equivalents associated with Solventum through its April 2024 separation from 3M that were presented in current assets of
discontinued operations in the 3M Consolidated Balance Sheet.
3M Company and Subsidiaries
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in millions)
(Unaudited)
3

-- 3 of 11 --

Three months ended March 31, 2025
Sales change analysis by geographic area Americas Asia Pacific Europe, Middle East
and Africa Worldwide
Organic sales 1.6 % (0.7) % (5.1) % (0.3) %
Divestitures 1.6 0.2 0.5 1.0
Translation (1.4) (2.1) (2.1) (1.7)
Total sales change 1.8 % (2.6) % (6.7) % (1.0) %
Three months ended March 31, 2025
Worldwide sales change by business segment Organic sales Acquisitions Divestitures Translation Total sales
change
Safety and Industrial 2.5 % — % — % (2.0) % 0.5 %
Transportation and Electronics (4.0) — — (1.4) (5.4)
Consumer 0.3 — — (1.7) (1.4)
2Total sales change is calculated based on reported sales results. The components of sales change include organic local-currency sales,
acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and
divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post-
transaction and, beginning April 2024, include the impact of commercial agreements associated with the separation of Solventum.
3M Company and Subsidiaries
SALES CHANGE ANALYSIS2
(Unaudited)
4

-- 4 of 11 --

3M discloses business segment operating income (loss) as its measure of segment profit/loss, reconciled to both total 3M
operating income (loss) and income before taxes. Business segment operating income (loss) excludes certain expenses and
income that are not allocated to business segments (as described below in “Corporate and Other”).
Three months ended
March 31,
Net sales (millions) 2025 2024
Abrasives $ 317 $ 328
Automotive Aftermarket 290 306
Electrical Markets 325 305
Industrial Adhesives and Tapes 543 518
Industrial Specialties Division 288 290
Personal Safety 850 857
Roofing Granules 132 128
Total Safety and Industrial business segment 2,745 2,732
Advanced Materials 218 263
Automotive and Aerospace 475 506
Commercial Branding and Transportation 616 610
Electronics 681 725
Total Transportation and Electronics business segment 1,990 2,104
Consumer Safety and Well-Being 274 266
Home and Auto Care 299 305
Home Improvement 326 330
Packaging and Expression 225 239
Total Consumer business segment 1,124 1,140
Total reportable business segments 5,859 5,976
Corporate and Other 95 40
Total company $ 5,954 $ 6,016
Operating income (loss) (millions)
Safety and Industrial $ 696 $ 657
Transportation and Electronics 352 481
Consumer 219 216
Total reportable business segments 1,267 1,354
Corporate and Other
Corporate special items:
Net costs for significant litigation (71) (63)
Divestiture costs — (6)
Total corporate special items (71) (69)
Other corporate (expense) income - net 50 (136)
Total Corporate and Other (21) (205)
Total company operating income (loss) 1,246 1,149
Other expense/(income), net (139) 220
Income (loss) from continuing operations before income taxes $ 1,385 $ 929
3M Company and Subsidiaries
BUSINESS SEGMENTS
(Unaudited)
5

-- 5 of 11 --

Corporate and Other
Outside of 3M's reportable operating segments, 3M has Corporate and Other which is not a reportable business segment as it
does not meet the segment reporting criteria. Because Corporate and Other includes a variety of miscellaneous items, it is
subject to fluctuation on a quarterly and annual basis.
Corporate and Other operating income (loss) includes “corporate special items” and “other corporate (expense) income-net”.
• Corporate special items includes, for the periods presented:
◦ net costs for significant litigation impacting operating income (loss) associated with PFAS-related other
environmental and Combat Arms Earplugs matters.
◦ divestiture costs (related to separating and divesting substantially an entire business segment of 3M following
public announcement of its intended divestiture) that were not eligible to be part of discontinued operations.
• Other corporate (expense) income-net includes:
◦ certain enterprise and governance activities resulting in unallocated corporate costs and other activity and net
costs that 3M may choose not to allocate directly to its business segments.
◦ commercial activity with Solventum following its April 1, 2024 Separation and certain operations of the
former Health Care business segment retained by 3M.
◦ transition arrangement agreements (e.g. fees charged by 3M, net of underlying costs) related to divested
businesses, including those related to the Solventum Separation, as well as other applicable divestitures.
◦ operations of businesses of the former Health Care segment divested prior to the Separation and therefore not
reflected as discontinued operations within 3M's financial statements, along with limited-duration supply
agreements with those previous divestitures.
◦ costs previously allocated to Solventum prior to the Separation that were not eligible to be part of
discontinued operations.
3M Company and Subsidiaries
BUSINESS SEGMENTS - (CONTINUED)
(Unaudited)
6

-- 6 of 11 --

In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides certain non-GAAP measures. These
measures are not in accordance with, nor are they a substitute for GAAP measures, and may not be comparable to similarly
titled measures used by other companies.
Certain measures adjust for the impacts of special items. Special items for the periods presented include the items described in
the section entitled “Description of special items”. Because 3M provides certain information with respect to business segments,
it is noteworthy that special items impacting operating income (loss) are reflected in Corporate and Other, except as described
with respect to net costs for significant litigation and manufactured PFAS products items in the “Description of special items”
section. The reconciliations below, therefore, also include impacted segments as applicable.
This document contains measures for which 3M provides the reported GAAP measure and a non-GAAP measure adjusted for
special items. The document also contains additional measures which are not defined under U.S. GAAP. These measures and
reasons 3M believes they are useful to investors (and, as applicable, used by 3M) include:
GAAP amounts for which a measure adjusted for
special items is also provided: Reasons 3M believes the measure is useful:
• Net sales (and sales change)
Considered, in addition to segment operating performance, in
evaluating and managing operations; useful in understanding
underlying business performance, provides additional transparency to
special items
• Operating income (loss), segment operating
income (loss) and operating income (loss) margin
• Other expense (income), net
• Income from continuing operations before taxes
• Provision for income taxes and effective tax rate
• Net income from continuing operations
• EPS from continuing operations
Additional non-GAAP measures:
• Adjusted net cash provided by (used in)
operating activities; adjusted purchases of
property, plant and equipment (also referred to as
adjusted capital expenditures); adjusted free cash
flow and adjusted free cash flow conversion
Used as indicators of strength and ability to generate cash and as
indicator of capital deployment; meaningful as measures of
performance
The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES
(Unaudited)
7

-- 7 of 11 --

Certain amounts adjusted for special items (non-GAAP measures):
Three months ended March 31, 2024
Amounts from continuing operations
(Dollars in millions, except per share
amounts) Net sales
Operating
income
(loss)
Operating
income
(loss)
margin
Income
(loss)
before
taxes
Provision
(benefit)
for
income
taxes Effective
tax rate
Net income
(loss)
attributable
to 3M EPS
Safety and Industrial
GAAP amounts $ 657 24.1 %
Adjustments for special items:
Net costs for significant litigation 7
Adjusted amounts (non-GAAP
measures)3 $ 664 24.3 %
Transportation and Electronics
GAAP amounts $ 2,104 $ 481 22.9 %
Adjustments for special items:
Manufactured PFAS products (281) (2)
Adjusted amounts (non-GAAP
measures)3 $ 1,823 $ 479 26.3 %
Total company
GAAP amounts $ 6,016 $ 1,149 19.1 % $ 929 $ 220 23.7 % $ 705 $ 1.27
Adjustments for special items:
Net costs for significant litigation — 70 274 31 243 0.44
Manufactured PFAS products (281) (2) (2) (1) (1) —
Divestiture costs — 6 6 2 4 —
Total special items (281) 74 278 32 246 0.44
Adjusted amounts (non-GAAP
measures)3 $ 5,735 $ 1,223 21.3 % $ 1,207 $ 252 20.9 % $ 951 $ 1.71
Three months ended March 31, 2025
Amounts from continuing operations
(Dollars in millions, except per share
amounts) Net sales
Sales
change
Operating
income
(loss)
Operating
income
(loss)
margin
Income
(loss)
before
taxes
Provision
(benefit)
for
income
taxes Effective
tax rate
Net income
(loss)
attributable
to 3M EPS
EPS
percent
change
Safety and Industrial
GAAP amounts $ 696 25.4 %
Adjustments for special items:
Net costs for significant litigation 3
Adjusted amounts (non-GAAP
measures)3 $ 699 25.5 %
Transportation and Electronics
GAAP amounts $ 1,990 (5.4) % $ 352 17.7 %
Adjustments for special items:
Manufactured PFAS products (174) 38
Adjusted amounts (non-GAAP
measures)3 $ 1,816 (0.4) % $ 390 21.5 %
Total company
GAAP amounts $ 5,954 (1.0) % $ 1,246 20.9 % $ 1,385 $ 265 19.1 % $ 1,116 $ 2.04 61 %
Adjustments for special items:
Net costs for significant litigation — 74 224 (2) 226 0.41
Manufactured PFAS products (174) 38 38 9 29 0.06
Solventum ownership - change in
value — — (343) — (343) (0.63)
Total special items (174) 112 (81) 7 (88) (0.16)
Adjusted amounts (non-GAAP
measures)3 $ 5,780 0.8 % $ 1,358 23.5 % $ 1,304 $ 272 20.9 % $ 1,028 $ 1.88 10 %
3These items represent amounts adjusted for special items. See lead-in to non-GAAP measures discussion.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
8

-- 8 of 11 --

2025 forecast
2025 adjusted earnings per share from continuing operations (non-GAAP measure)3,5 $7.60 to $7.90
53M provides these forward-looking non-GAAP measures, but cannot, without unreasonable effort, forecast certain items to present or
provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as net costs for significant
litigation; projected divestiture gains; divestiture costs; divestiture-related restructuring; changes in value of Solventum ownership; and
net sales and estimates of income and associated activity of exited manufactured PFAS products all of which are subject to limitations in
predictability of timing, ultimate outcome and numerous conditions outside of 3M’s control. 3M believes these limitations would result
in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance
of such information is low. Additionally, for similar reasons, 3M does not include the impact of potentially-divested or acquired
businesses on expected operations in forecasted guidance it provides until close of a transaction. Information with respect to special
items for certain historical periods is included in the section entitled “Description of special items”.
Three months ended March 31, 2025
Sales change2
Organic
sales Acquisitions Divestitures Translation Total sales
change
Total company (0.3) % — % 1.0 % (1.7) % (1.0) %
Remove manufactured PFAS products special item impact 1.8 — — — 1.8
Adjusted total company (non-GAAP measures)3 1.5 % — % 1.0 % (1.7) % 0.8 %
Transportation and Electronics (4.0) % — % — % (1.4) % (5.4) %
Remove manufactured PFAS products special item impact 5.1 — — (0.1) 5.0
Adjusted Transportation and Electronics (non-GAAP measures)3 1.1 % — % — % (1.5) % (0.4) %
By Geographic Area
Americas 1.6 % — % 1.6 % (1.4) % 1.8 %
Remove manufactured PFAS products special item impact 0.1 — — — 0.1
Adjusted Americas (non-GAAP measures)3 1.7 % — % 1.6 % (1.4) % 1.9 %
Asia Pacific (0.7) % — % 0.2 % (2.1) % (2.6) %
Remove manufactured PFAS products special item impact 3.8 — — — 3.8
Adjusted Asia Pacific (non-GAAP measures)3 3.1 % — % 0.2 % (2.1) % 1.2 %
Europe, Middle East & Africa (5.1) % — % 0.5 % (2.1) % (6.7) %
Remove manufactured PFAS products special item impact 3.5 — 0.1 (0.1) 3.5
Adjusted Europe, Middle East & Africa (non-GAAP measures)3 (1.6) % — % 0.6 % (2.2) % (3.2) %
By Particular Country
United States 0.9 % — % 2.0 % — % 2.9 %
Remove manufactured PFAS products special item impact 0.1 — — — 0.1
Adjusted United States (non-GAAP measures)3 1.0 % — % 2.0 % — % 3.0 %
China 3.5 % — % 0.4 % (0.8) % 3.1 %
Remove manufactured PFAS products special item impact 1.7 — 0.1 (0.1) 1.7
Adjusted China (non-GAAP measures)3 5.2 % — % 0.5 % (0.9) % 4.8 %
Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also
referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion (non-
GAAP measures):
Three months ended
March 31,
Major GAAP cash flow categories (dollars in millions) 2025 2024
Net cash provided by (used in) operating activities $ (79) $ 767
Net cash provided by (used in) investing activities 1,220 (393)
Net cash provided by (used in) financing activities (422) 4,621
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
9

-- 9 of 11 --

Three months ended
March 31,
Adjusted free cash flow (non-GAAP measure) (dollars in millions) 2025 2024
Net cash provided by (used in) operating activities $ (79) $ 767
Adjustments for special items:
Net costs for significant litigation after-tax payment impacts 787 351
Divestiture costs after-tax payment impacts 16 139
Divestiture-related restructuring after-tax payment impacts — 1
Manufactured PFAS products impact after-tax payment impacts (7) (70)
Total adjustments for special items 796 421
Adjusted net cash provided by (used in) operating activities (non-GAAP measure)4 $ 717 $ 1,188
Purchases of property, plant and equipment (PPE) (236) (375)
Manufactured PFAS products impact - removing related purchases of PPE 8 20
Adjusted purchases of PPE (non-GAAP measure)4 $ (228) $ (355)
Adjusted free cash flow (non-GAAP measure)4 $ 489 $ 833
Net income (loss) attributable to 3M $ 1,116 $ 928
Adjustments for special items, net of tax:
Net costs for significant litigation 226 243
Manufactured PFAS products impact 29 (1)
Divestiture costs — 157
Solventum ownership - change in value (343) —
Total adjustments for special items, net of tax (88) 399
Net income (loss) attributable to 3M adjusted for special items
(used for adjusted free cash flow calculation)
$ 1,028 $ 1,327
Adjusted free cash flow conversion (non-GAAP measure)4 48 % 63 %
43M’s Consolidated Statements of Cash Flows include the results of continuing and discontinued operations (Solventum separated from 3M
in April 2024); accordingly, amounts associated with the determination of adjusted free cash flow include both continuing and discontinued
operations in certain periods both from an income and cash flow perspective. 3M defines adjusted net cash provided by (used in) operating
activities as net cash provided by operating activities, adjusted for special items. 3M defines adjusted purchases of property, plant and
equipment (also referred to as adjusted capital expenditures) as purchases of property, plant and equipment (PPE) adjusted for the estimated
impact of such purchases associated with manufactured PFAS products activity. 3M defines adjusted free cash flow as adjusted net cash
provided by (used in) operating activities less adjusted purchases of PPE. Cash payments/receipts associated with special items in the
determination of adjusted net cash provided by (used in) operating activities are reflected net of applicable tax. The cash tax impact for the
portion of payments of costs for significant litigation under the 2023 settlement agreements relative to Combat Arms Earplugs and relative to
public water systems regarding PFAS is based on the timing/amount of the actual cash tax deduction (which differs from the timing of the
pre-tax cash settlement payments). The impacts of certain tax-related divestiture costs are based on applicable tax rates and the timing of tax
payments relative to underlying Separation transactions. For other special items, the cash tax impact is estimated using the U.S. statutory
corporate tax rate during the period of payment/receipt. Tax impacts include associated impacts on Foreign Derived Intangible Income (FDII),
Global Intangible Low Taxed Income (GILTI), foreign tax credits, and tax costs of repatriation. 3M defines adjusted free cash flow
conversion as adjusted free cash flow divided by net income (loss) attributable to 3M, adjusted for special items (used for adjusted free cash
flow calculation).
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
10

-- 10 of 11 --

Description of special items:
In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP
measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these
non-GAAP measures for the periods presented include the items described below:
Net costs for significant litigation:
• These relate to 3M's respirator mask/asbestos (which include Aearo and non-Aearo items), PFAS-related other
environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities
(including interest imputation on applicable settlement obligations), legal costs, and insurance recoveries, along with the
associated tax impacts. Associated tax impacts of significant litigation include impacts on Foreign Derived Intangible
Income (FDII), Global Intangible Low Taxed Income (GILTI), foreign tax credits and tax costs of repatriation. 3M does
not consider the elements of the net costs associated with these matters to be normal, operating expenses related to the
Company’s ongoing operations, revenue generating activities, business strategy, industry, and regulatory environment.
Net costs related to respirator mask/asbestos are reflected as special items in the Safety and Industrial business segment
while those impacting operating income (loss) associated with PFAS-related other environmental and Combat Arms
Earplugs matters are reflected as corporate special items in Corporate and Other. In the first quarter of 2025 and 2024,
3M reflected net pre-tax cash (receipts)/payments of approximately $806 million and $371 million, respectively, related
to net costs for significant litigation.
Divestiture costs:
• These include certain limited costs that were not eligible to be included within discontinued operations related to
separating and divesting substantially an entire business segment of 3M following public announcement of its intended
divestiture. As a result of completion of the April 2024 separation of Solventum, this includes the tax cost of updating
3M’s previous indefinite reinvestment plans on past unrepatriated earnings through the period of the Separation’s close
and to tax positions retained by 3M. 3M’s statement of cash flows includes the results of both continuing and
discontinued operations. Therefore, in the context of amounts used in the determination of non-GAAP measures
associated with cash flow and adjusted free cash flow conversion, this special item further includes the broader extent of
such costs that included within discontinued operations, including interest expense on debt issued by Solventum for the
period outstanding prior to the April 1, 2024 completion of the separation of Solventum from 3M and net tax costs of
entity structuring associated with the separation of Solventum. In the first quarter of 2024, 3M made pre-tax cash
payments of approximately $134 million associated with divestiture costs.
Divestiture-related restructuring actions:
• In the third quarter of 2022, following the split-off of the Food Safety business, management approved and committed to
undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude of
amounts previously allocated to the divested business. In the first quarter of 2024, 3M made pre-tax cash payments of
approximately $2 million associated with divestiture-related restructuring actions.
Manufactured PFAS products:
• These amounts relate to sales and estimates of income (loss) and associated activity regarding manufactured PFAS
products that 3M plans to exit by the end of 2025 included within the Transportation and Electronics business segment.
Estimated income does not contemplate impacts on non-operating items such as net interest income/expense and the non-
service cost components portion of defined benefit plan net periodic benefit costs. Relative to the impact of the activity
of manufactured PFAS products on cash provided by (used in) operating activities, amounts are based on estimates of
associated income, depreciation/amortization, certain changes in working capital and accruals, and timing of associated
payments.
Solventum ownership - change in value:
• This amount relates to the change in value of 3M's retained ownership interest in Solventum common stock reflected in
other expense (income), net.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
11

-- 11 of 11 --